Literature DB >> 15879675

Abrogation of bronchial eosinophilic inflammation and attenuated eotaxin content in protease-activated receptor 2-deficient mice.

Toshiaki Takizawa1, Masaki Tamiya, Takuya Hara, Jiro Matsumoto, Naohiro Saito, Toru Kanke, Junichi Kawagoe, Yukio Hattori.   

Abstract

Protease-activated receptor 2 (PAR2) belongs to the PAR family (PAR1 to PAR4), which is activated by serine proteases (trypsin, tryptase, etc.). In this study, we evaluated the role of PAR2 in allergic inflammation of airways using PAR2-deficient (PAR2(-/-)) mice. In wild- type mice, infiltration of eosinophils and high eotaxin content were found in bronchoalveolar lavage fluid (BALF) after ovalbumin (OA) sensitization and following challenge. In contrast, both OA-induced infiltration of eosinophils and increase of eotaxin content were abrogated in BALF from PAR2(-/-) mice. The activation of PAR2 might be essential in the production of eotaxin and consequential allergic inflammation in airways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879675     DOI: 10.1254/jphs.scz050138

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  18 in total

Review 1.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

Review 2.  Tolerizing allergic responses in the lung.

Authors:  C M Lloyd; J R Murdoch
Journal:  Mucosal Immunol       Date:  2010-05-26       Impact factor: 7.313

3.  A highly potent agonist to protease-activated receptor-2 reveals apical activation of the airway epithelium resulting in Ca2+-regulated ion conductance.

Authors:  Cara L Sherwood; Michael O Daines; Theodore J Price; Josef Vagner; Scott Boitano
Journal:  Am J Physiol Cell Physiol       Date:  2014-10-15       Impact factor: 4.249

4.  The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo.

Authors:  Scott Boitano; Justin Hoffman; Andrea N Flynn; Marina N Asiedu; Dipti V Tillu; Zhenyu Zhang; Cara L Sherwood; Candy M Rivas; Kathryn A DeFea; Josef Vagner; Theodore J Price
Journal:  Br J Pharmacol       Date:  2015-08-03       Impact factor: 8.739

Review 5.  Role for β-arrestin in mediating paradoxical β2AR and PAR2 signaling in asthma.

Authors:  Julia K L Walker; Katherine A DeFea
Journal:  Curr Opin Pharmacol       Date:  2014-06-05       Impact factor: 5.547

6.  Role of Aspergillus fumigatus in Triggering Protease-Activated Receptor-2 in Airway Epithelial Cells and Skewing the Cells toward a T-helper 2 Bias.

Authors:  Tetsuya Homma; Atsushi Kato; Bharat Bhushan; James E Norton; Lydia A Suh; Roderick G Carter; Dave S Gupta; Robert P Schleimer
Journal:  Am J Respir Cell Mol Biol       Date:  2016-01       Impact factor: 6.914

7.  Profiling gene expression induced by protease-activated receptor 2 (PAR2) activation in human kidney cells.

Authors:  Jacky Y Suen; Brooke Gardiner; Sean Grimmond; David P Fairlie
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

8.  A severe deficiency of coagulation factor VIIa results in attenuation of the asthmatic response in mice.

Authors:  Kazuhiko Shinagawa; Victoria A Ploplis; Francis J Castellino
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-03-13       Impact factor: 5.464

Review 9.  Protease-activated receptors and prostaglandins in inflammatory lung disease.

Authors:  Terence Peters; Peter J Henry
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

10.  Protease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivo.

Authors:  Giancarlo Ramelli; Silvia Fuertes; Sharmal Narayan; Nathalie Busso; Hans Acha-Orbea; Alexander So
Journal:  Immunology       Date:  2009-06-22       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.